Figure PDU-4:  Estimated trends in the prevalence of problem drug use 1995 to 2004 (rate per 1000 population aged 15 to 64) – Part (i) Combined estimates per country (overall prevalence)

Figure PDU-04 part i

Notes:

Time series are combined where methods are similar over the time span, this is less clear for UK where the trend may therefore be less reliable. Spain and Luxembourg each have two different time series. For more details see Table PDU-1 to Table PDU-3. Target groups may vary between countries owing to different methods and data sources; therefore comparisons should be made with caution. In some countries data are insufficient to report. The estimates of Czech Republic refer to the age group 18-64.

See also 'General notes for interpreting data' on the Explanatory notes and help page.

Sources:

National Focal Points. See also EMCDDA project (2003): National prevalence estimates of problem drug use in the European Union, 1995–2000, CT.00.RTX.23, EMCDDA, Lisbon, coordinated by the Institut für Therapieforschung, Munich (http://www.emcdda.europa.eu/?nnodeid=1372).